

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of respiratory burst (GO:0060267) | 9.19545088 |
| 2 | glomerular filtration (GO:0003094) | 7.70256285 |
| 3 | protein activation cascade (GO:0072376) | 7.60000444 |
| 4 | renal filtration (GO:0097205) | 6.93241972 |
| 5 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 6.34017610 |
| 6 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 6.34017610 |
| 7 | Fc-gamma receptor signaling pathway (GO:0038094) | 6.34017610 |
| 8 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 6.30813770 |
| 9 | regulation of respiratory burst (GO:0060263) | 6.10143496 |
| 10 | humoral immune response (GO:0006959) | 5.83854848 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.67623716 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.67217198 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.63596243 |
| 14 | retina homeostasis (GO:0001895) | 4.65440102 |
| 15 | antibacterial humoral response (GO:0019731) | 4.60384865 |
| 16 | antimicrobial humoral response (GO:0019730) | 4.55825338 |
| 17 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.42102667 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.38834587 |
| 19 | positive regulation of antigen processing and presentation (GO:0002579) | 4.02009954 |
| 20 | regulation of antigen processing and presentation (GO:0002577) | 4.01653642 |
| 21 | germinal center formation (GO:0002467) | 3.99278755 |
| 22 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.97015001 |
| 23 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.92896995 |
| 24 | cellular response to type I interferon (GO:0071357) | 3.91825704 |
| 25 | type I interferon signaling pathway (GO:0060337) | 3.91825704 |
| 26 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.88715034 |
| 27 | response to type I interferon (GO:0034340) | 3.88334550 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.77717249 |
| 29 | regulation of cellular extravasation (GO:0002691) | 3.65924941 |
| 30 | detection of bacterium (GO:0016045) | 3.63627479 |
| 31 | detection of other organism (GO:0098543) | 3.60383138 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.45527454 |
| 33 | negative regulation of cell killing (GO:0031342) | 3.45527454 |
| 34 | negative regulation of myotube differentiation (GO:0010832) | 3.41543910 |
| 35 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.39865136 |
| 36 | chronic inflammatory response (GO:0002544) | 3.32427765 |
| 37 | B cell mediated immunity (GO:0019724) | 3.32008926 |
| 38 | dendritic cell chemotaxis (GO:0002407) | 3.20465924 |
| 39 | surfactant homeostasis (GO:0043129) | 3.12857894 |
| 40 | protein-chromophore linkage (GO:0018298) | 3.08437294 |
| 41 | cellular response to interferon-gamma (GO:0071346) | 3.05363328 |
| 42 | negative regulation of complement activation (GO:0045916) | 3.04485454 |
| 43 | regulation of integrin activation (GO:0033623) | 3.02808755 |
| 44 | response to interferon-gamma (GO:0034341) | 2.98132838 |
| 45 | immune response-activating signal transduction (GO:0002757) | 2.97333717 |
| 46 | response to interferon-beta (GO:0035456) | 2.94953941 |
| 47 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93533303 |
| 48 | activation of immune response (GO:0002253) | 2.93340540 |
| 49 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.88022473 |
| 50 | negative regulation of humoral immune response (GO:0002921) | 2.85814627 |
| 51 | myeloid dendritic cell differentiation (GO:0043011) | 2.82536049 |
| 52 | positive regulation of type 2 immune response (GO:0002830) | 2.78508129 |
| 53 | regulation of regulatory T cell differentiation (GO:0045589) | 2.77927619 |
| 54 | detection of external biotic stimulus (GO:0098581) | 2.74977516 |
| 55 | dendritic cell migration (GO:0036336) | 2.73939184 |
| 56 | positive regulation of neutrophil migration (GO:1902624) | 2.71933595 |
| 57 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.71933595 |
| 58 | myeloid dendritic cell activation (GO:0001773) | 2.71875994 |
| 59 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.70476219 |
| 60 | B cell receptor signaling pathway (GO:0050853) | 2.69679946 |
| 61 | negative regulation of protein activation cascade (GO:2000258) | 2.69560951 |
| 62 | wound healing, spreading of epidermal cells (GO:0035313) | 2.69384820 |
| 63 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.69337617 |
| 64 | positive regulation of T cell migration (GO:2000406) | 2.69172149 |
| 65 | T-helper 1 type immune response (GO:0042088) | 2.67478466 |
| 66 | production of molecular mediator of immune response (GO:0002440) | 2.66560804 |
| 67 | lymphocyte chemotaxis (GO:0048247) | 2.64454614 |
| 68 | NIK/NF-kappaB signaling (GO:0038061) | 2.62126219 |
| 69 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.61401510 |
| 70 | positive thymic T cell selection (GO:0045059) | 2.59332814 |
| 71 | respiratory burst (GO:0045730) | 2.56947639 |
| 72 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.55629107 |
| 73 | regulation of T cell tolerance induction (GO:0002664) | 2.54558262 |
| 74 | negative regulation of bone resorption (GO:0045779) | 2.53503539 |
| 75 | regulation of T cell migration (GO:2000404) | 2.52863753 |
| 76 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.52655116 |
| 77 | regulation of gamma-delta T cell activation (GO:0046643) | 2.51908835 |
| 78 | interferon-gamma secretion (GO:0072643) | 2.51224300 |
| 79 | eosinophil chemotaxis (GO:0048245) | 2.45863565 |
| 80 | positive regulation of chemokine secretion (GO:0090197) | 2.45364779 |
| 81 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.45330799 |
| 82 | cellular extravasation (GO:0045123) | 2.42066159 |
| 83 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.41831867 |
| 84 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 2.40318038 |
| 85 | COPI coating of Golgi vesicle (GO:0048205) | 2.39395512 |
| 86 | Golgi transport vesicle coating (GO:0048200) | 2.39395512 |
| 87 | T cell costimulation (GO:0031295) | 2.38693271 |
| 88 | positive regulation of lymphocyte migration (GO:2000403) | 2.38567247 |
| 89 | response to interleukin-15 (GO:0070672) | 2.38191346 |
| 90 | regulation of chemokine secretion (GO:0090196) | 2.37960753 |
| 91 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.37696657 |
| 92 | positive regulation of B cell differentiation (GO:0045579) | 2.35632392 |
| 93 | response to interferon-alpha (GO:0035455) | 2.35625395 |
| 94 | lymphocyte costimulation (GO:0031294) | 2.35319339 |
| 95 | peptide catabolic process (GO:0043171) | 2.34653920 |
| 96 | negative regulation of innate immune response (GO:0045824) | 2.34638906 |
| 97 | positive regulation of pseudopodium assembly (GO:0031274) | 2.34625483 |
| 98 | positive regulation of response to oxidative stress (GO:1902884) | 2.34617232 |
| 99 | complement activation, classical pathway (GO:0006958) | 13.1448645 |
| 100 | complement activation (GO:0006956) | 10.3536539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.18609964 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.68415569 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.17144933 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.57052153 |
| 5 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.38981736 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.16636355 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.86497999 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.82843520 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.70967438 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.58201123 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28866239 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.27650635 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26912900 |
| 14 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.04389428 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03113541 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01876324 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.95841699 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90999679 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.84287858 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80623336 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.79238266 |
| 22 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.78460095 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77330045 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.74745769 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69299499 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58803955 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.56674216 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55747529 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47353726 |
| 30 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.37248500 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.36071694 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35631946 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.35485599 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35373898 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.35308178 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.34095742 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32214570 |
| 38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30882954 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29345949 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.28377520 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26883304 |
| 42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.26582814 |
| 43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.24916435 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24254883 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23124988 |
| 46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22488072 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22292249 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20021788 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17477001 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.16867606 |
| 51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14283670 |
| 52 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13387465 |
| 53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.12739224 |
| 54 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12718834 |
| 55 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.12306579 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.11966253 |
| 57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10635728 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10617749 |
| 59 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10592356 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10389363 |
| 61 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09837896 |
| 62 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08914994 |
| 63 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08813341 |
| 64 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08331407 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06609384 |
| 66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06388017 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02715400 |
| 68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01849864 |
| 69 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01520312 |
| 70 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00584133 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00124616 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99386606 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98599326 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98441811 |
| 75 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97929914 |
| 76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96290318 |
| 77 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.95155733 |
| 78 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.94746804 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94576467 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94469042 |
| 81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94468733 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93695910 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90942035 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90793869 |
| 85 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90761153 |
| 86 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.89996378 |
| 87 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88119023 |
| 88 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87857433 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86913728 |
| 90 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86029476 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84420990 |
| 92 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83937450 |
| 93 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83700072 |
| 94 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.82480182 |
| 95 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.82323326 |
| 96 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82140699 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81141078 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80134179 |
| 99 | GATA3_26560356_Chip-Seq_TH2_Human | 0.77639205 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77389964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.87079417 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.74311703 |
| 3 | MP0003303_peritoneal_inflammation | 3.58508161 |
| 4 | MP0001790_abnormal_immune_system | 3.26337170 |
| 5 | MP0005387_immune_system_phenotype | 3.26337170 |
| 6 | MP0003436_decreased_susceptibility_to | 3.16990670 |
| 7 | MP0000685_abnormal_immune_system | 2.97851258 |
| 8 | MP0001800_abnormal_humoral_immune | 2.84571382 |
| 9 | MP0005025_abnormal_response_to | 2.68082439 |
| 10 | MP0010155_abnormal_intestine_physiology | 2.54498656 |
| 11 | MP0009785_altered_susceptibility_to | 2.52918066 |
| 12 | MP0005671_abnormal_response_to | 2.48411591 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.43236301 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.40848398 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.30185403 |
| 16 | MP0000465_gastrointestinal_hemorrhage | 2.27934433 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.26284564 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.17940636 |
| 19 | MP0002723_abnormal_immune_serum | 2.12659175 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 2.07608357 |
| 21 | MP0002419_abnormal_innate_immunity | 2.06798449 |
| 22 | MP0005275_abnormal_skin_tensile | 2.02738173 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.02270433 |
| 24 | MP0001819_abnormal_immune_cell | 1.99795456 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.99568205 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.93415337 |
| 27 | MP0001873_stomach_inflammation | 1.89481771 |
| 28 | MP0005166_decreased_susceptibility_to | 1.87414774 |
| 29 | MP0003866_abnormal_defecation | 1.81966288 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.76021125 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.71058701 |
| 32 | MP0004947_skin_inflammation | 1.69894329 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.69146919 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 1.68756141 |
| 35 | MP0004782_abnormal_surfactant_physiolog | 1.68274246 |
| 36 | MP0008004_abnormal_stomach_pH | 1.54855430 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.53274378 |
| 38 | MP0006082_CNS_inflammation | 1.52658842 |
| 39 | MP0005503_abnormal_tendon_morphology | 1.50497812 |
| 40 | MP0000716_abnormal_immune_system | 1.47940947 |
| 41 | MP0005023_abnormal_wound_healing | 1.42555418 |
| 42 | MP0002398_abnormal_bone_marrow | 1.38862269 |
| 43 | MP0000858_altered_metastatic_potential | 1.37952682 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.36711867 |
| 45 | MP0003448_altered_tumor_morphology | 1.36629526 |
| 46 | MP0002405_respiratory_system_inflammati | 1.35214978 |
| 47 | MP0002277_abnormal_respiratory_mucosa | 1.33830439 |
| 48 | MP0003279_aneurysm | 1.33442027 |
| 49 | MP0001663_abnormal_digestive_system | 1.30687158 |
| 50 | MP0005310_abnormal_salivary_gland | 1.28577259 |
| 51 | MP0002006_tumorigenesis | 1.26097707 |
| 52 | MP0003075_altered_response_to | 1.24393789 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.24280149 |
| 54 | MP0002139_abnormal_hepatobiliary_system | 1.23333337 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.23266182 |
| 56 | MP0002933_joint_inflammation | 1.23170202 |
| 57 | MP0000343_altered_response_to | 1.21501769 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.20025584 |
| 59 | MP0008469_abnormal_protein_level | 1.17864178 |
| 60 | MP0002429_abnormal_blood_cell | 1.17647424 |
| 61 | MP0009278_abnormal_bone_marrow | 1.14963410 |
| 62 | MP0009764_decreased_sensitivity_to | 1.10934427 |
| 63 | MP0005390_skeleton_phenotype | 1.10825706 |
| 64 | MP0001542_abnormal_bone_strength | 1.07518470 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.07252572 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.06749797 |
| 67 | MP0000604_amyloidosis | 1.06513425 |
| 68 | MP0001986_abnormal_taste_sensitivity | 1.04994568 |
| 69 | MP0002722_abnormal_immune_system | 1.03293939 |
| 70 | MP0001851_eye_inflammation | 1.01846064 |
| 71 | MP0003045_fibrosis | 0.98105501 |
| 72 | MP0000477_abnormal_intestine_morphology | 0.96143355 |
| 73 | MP0005381_digestive/alimentary_phenotyp | 0.95755401 |
| 74 | MP0004858_abnormal_nervous_system | 0.94219384 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 0.93445466 |
| 76 | MP0005164_abnormal_response_to | 0.92909621 |
| 77 | MP0009840_abnormal_foam_cell | 0.92619312 |
| 78 | MP0000490_abnormal_crypts_of | 0.90614933 |
| 79 | MP0005165_increased_susceptibility_to | 0.90176776 |
| 80 | MP0000249_abnormal_blood_vessel | 0.86262597 |
| 81 | MP0005257_abnormal_intraocular_pressure | 0.82944445 |
| 82 | MP0005085_abnormal_gallbladder_physiolo | 0.81646349 |
| 83 | MP0003868_abnormal_feces_composition | 0.79701221 |
| 84 | MP0003828_pulmonary_edema | 0.79378653 |
| 85 | MP0004510_myositis | 0.76507713 |
| 86 | MP0005388_respiratory_system_phenotype | 0.76203624 |
| 87 | MP0002133_abnormal_respiratory_system | 0.76203624 |
| 88 | MP0001958_emphysema | 0.76151376 |
| 89 | MP0005365_abnormal_bile_salt | 0.75587009 |
| 90 | MP0002060_abnormal_skin_morphology | 0.75271729 |
| 91 | MP0000681_abnormal_thyroid_gland | 0.75183819 |
| 92 | MP0001879_abnormal_lymphatic_vessel | 0.74474703 |
| 93 | MP0001666_abnormal_nutrient_absorption | 0.73916457 |
| 94 | MP0003795_abnormal_bone_structure | 0.73102904 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.72197209 |
| 96 | MP0010368_abnormal_lymphatic_system | 0.72050237 |
| 97 | MP0002396_abnormal_hematopoietic_system | 0.71753343 |
| 98 | MP0002796_impaired_skin_barrier | 0.71694556 |
| 99 | MP0003566_abnormal_cell_adhesion | 0.69896597 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 0.69647789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prostate neoplasm (HP:0100787) | 9.59084266 |
| 2 | Abnormality of macrophages (HP:0004311) | 6.20212858 |
| 3 | Abnormality of the prostate (HP:0008775) | 6.10320455 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.86204500 |
| 5 | Agammaglobulinemia (HP:0004432) | 4.80231057 |
| 6 | Recurrent bronchitis (HP:0002837) | 4.40624898 |
| 7 | Vasculitis (HP:0002633) | 4.38612957 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.03669862 |
| 9 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.83644007 |
| 10 | Leukocytosis (HP:0001974) | 3.78451402 |
| 11 | Skin rash (HP:0000988) | 3.74049617 |
| 12 | Abnormality of male internal genitalia (HP:0000022) | 3.71331475 |
| 13 | Abnormality of complement system (HP:0005339) | 3.63323322 |
| 14 | Malnutrition (HP:0004395) | 3.56407193 |
| 15 | Gastrointestinal stroma tumor (HP:0100723) | 3.54008252 |
| 16 | Complement deficiency (HP:0004431) | 3.45122071 |
| 17 | Cellulitis (HP:0100658) | 3.39854039 |
| 18 | Glomerulonephritis (HP:0000099) | 3.37206738 |
| 19 | Meningitis (HP:0001287) | 3.29484968 |
| 20 | Premature loss of primary teeth (HP:0006323) | 3.17865629 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.14055720 |
| 22 | Osteomyelitis (HP:0002754) | 3.01678164 |
| 23 | Abnormality of B cell number (HP:0010975) | 2.97037061 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.91232394 |
| 25 | Spontaneous hematomas (HP:0007420) | 2.90906638 |
| 26 | Nephritis (HP:0000123) | 2.90509261 |
| 27 | Colitis (HP:0002583) | 2.90245824 |
| 28 | Hyperactive renin-angiotensin system (HP:0000841) | 2.89099198 |
| 29 | Neoplasm of the lung (HP:0100526) | 2.87865549 |
| 30 | Recurrent abscess formation (HP:0002722) | 2.87727380 |
| 31 | Recurrent bacterial skin infections (HP:0005406) | 2.83362787 |
| 32 | Bronchitis (HP:0012387) | 2.79047564 |
| 33 | Increased IgE level (HP:0003212) | 2.77980060 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 2.72682637 |
| 35 | Inflammation of the large intestine (HP:0002037) | 2.66532537 |
| 36 | Myositis (HP:0100614) | 2.62375489 |
| 37 | Recurrent viral infections (HP:0004429) | 2.61194644 |
| 38 | Chronic otitis media (HP:0000389) | 2.57464957 |
| 39 | Urticaria (HP:0001025) | 2.56806501 |
| 40 | Chronic sinusitis (HP:0011109) | 2.53845062 |
| 41 | Gastrointestinal inflammation (HP:0004386) | 2.52843531 |
| 42 | Abnormality of the nasal mucosa (HP:0000433) | 2.51077033 |
| 43 | Neoplasm of the respiratory system (HP:0100606) | 2.48338176 |
| 44 | Gingivitis (HP:0000230) | 2.47526865 |
| 45 | Orchitis (HP:0100796) | 2.47429376 |
| 46 | B lymphocytopenia (HP:0010976) | 2.44975271 |
| 47 | Persistence of primary teeth (HP:0006335) | 2.43538312 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.42892002 |
| 49 | Recurrent fungal infections (HP:0002841) | 2.40648032 |
| 50 | Recurrent pneumonia (HP:0006532) | 2.39076656 |
| 51 | Hemoptysis (HP:0002105) | 2.38280963 |
| 52 | Hypermelanotic macule (HP:0001034) | 2.37050853 |
| 53 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.36866509 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33495500 |
| 55 | Obstructive lung disease (HP:0006536) | 2.33495500 |
| 56 | Emphysema (HP:0002097) | 2.32538825 |
| 57 | Recurrent lower respiratory tract infections (HP:0002783) | 2.30128979 |
| 58 | Recurrent sinusitis (HP:0011108) | 2.28066529 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.27937593 |
| 60 | Panhypogammaglobulinemia (HP:0003139) | 2.26614433 |
| 61 | Papilloma (HP:0012740) | 2.24605730 |
| 62 | Verrucae (HP:0200043) | 2.24605730 |
| 63 | Autoimmune hemolytic anemia (HP:0001890) | 2.23853811 |
| 64 | Mediastinal lymphadenopathy (HP:0100721) | 2.20464380 |
| 65 | Decreased circulating renin level (HP:0003351) | 2.20183935 |
| 66 | Pulmonary infiltrates (HP:0002113) | 2.19402165 |
| 67 | Villous atrophy (HP:0011473) | 2.19203407 |
| 68 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.19203407 |
| 69 | Purpura (HP:0000979) | 2.17594521 |
| 70 | Chronic diarrhea (HP:0002028) | 2.14684942 |
| 71 | Recurrent skin infections (HP:0001581) | 2.13175590 |
| 72 | Increased IgM level (HP:0003496) | 2.10709055 |
| 73 | Sepsis (HP:0100806) | 2.08353836 |
| 74 | Retrobulbar optic neuritis (HP:0100654) | 2.07728799 |
| 75 | Optic neuritis (HP:0100653) | 2.07728799 |
| 76 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.06624944 |
| 77 | Skin ulcer (HP:0200042) | 2.06340278 |
| 78 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04691321 |
| 79 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04691321 |
| 80 | Abnormality of primary teeth (HP:0006481) | 2.01856738 |
| 81 | Periodontitis (HP:0000704) | 2.01728662 |
| 82 | Right ventricular cardiomyopathy (HP:0011663) | 1.98814132 |
| 83 | Abnormality of T cell number (HP:0011839) | 1.98277138 |
| 84 | Restrictive lung disease (HP:0002091) | 1.97023444 |
| 85 | Autoimmune thrombocytopenia (HP:0001973) | 1.96845911 |
| 86 | Metaphyseal cupping (HP:0003021) | 1.96450476 |
| 87 | Abnormality of T cell physiology (HP:0011840) | 1.95567437 |
| 88 | Fragile skin (HP:0001030) | 1.95452299 |
| 89 | Xerostomia (HP:0000217) | 1.92866352 |
| 90 | Abnormality of the peritoneum (HP:0002585) | 1.90460740 |
| 91 | Abnormality of T cells (HP:0002843) | 1.88862149 |
| 92 | Lymphopenia (HP:0001888) | 1.87496321 |
| 93 | Thyroiditis (HP:0100646) | 1.86723294 |
| 94 | Ankyloglossia (HP:0010296) | 1.85232719 |
| 95 | Eosinophilia (HP:0001880) | 1.84999242 |
| 96 | Nasal polyposis (HP:0100582) | 1.84416073 |
| 97 | Alopecia of scalp (HP:0002293) | 1.83395719 |
| 98 | Granulocytopenia (HP:0001913) | 1.82035041 |
| 99 | Pustule (HP:0200039) | 1.79888383 |
| 100 | Polygenic inheritance (HP:0010982) | 1.79811958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.46781431 |
| 2 | TESK2 | 4.32557821 |
| 3 | TYK2 | 3.61761587 |
| 4 | MAP4K1 | 3.03213797 |
| 5 | MST1R | 2.95848011 |
| 6 | FGFR4 | 2.84018992 |
| 7 | BLK | 2.76035916 |
| 8 | RIPK4 | 2.50457475 |
| 9 | RIPK1 | 2.31306539 |
| 10 | KIT | 2.29686008 |
| 11 | EPHA3 | 2.27007123 |
| 12 | PRPF4B | 2.10831849 |
| 13 | JAK1 | 2.09056224 |
| 14 | SIK3 | 1.84475810 |
| 15 | IKBKE | 1.82613433 |
| 16 | JAK3 | 1.75115365 |
| 17 | EPHB1 | 1.73247516 |
| 18 | CDC42BPA | 1.69917550 |
| 19 | GRK1 | 1.68557923 |
| 20 | FES | 1.67844469 |
| 21 | GRK6 | 1.66835364 |
| 22 | MAP3K14 | 1.65440117 |
| 23 | FGFR3 | 1.64588272 |
| 24 | EPHA2 | 1.58885254 |
| 25 | TBK1 | 1.52926259 |
| 26 | CSK | 1.48107712 |
| 27 | PIK3CA | 1.46103604 |
| 28 | ZAP70 | 1.44946504 |
| 29 | SYK | 1.43725808 |
| 30 | LYN | 1.42572369 |
| 31 | TXK | 1.33700003 |
| 32 | IRAK4 | 1.33601220 |
| 33 | JAK2 | 1.21681721 |
| 34 | MAP3K13 | 1.20788224 |
| 35 | MAP3K1 | 1.19407963 |
| 36 | MATK | 1.18839971 |
| 37 | FER | 1.18608785 |
| 38 | PDGFRA | 1.15166226 |
| 39 | CSF1R | 1.10804235 |
| 40 | MET | 1.05453761 |
| 41 | NLK | 1.00088333 |
| 42 | IRAK1 | 0.99278785 |
| 43 | SMG1 | 0.98397176 |
| 44 | TGFBR2 | 0.95239666 |
| 45 | BTK | 0.92346961 |
| 46 | HCK | 0.89247323 |
| 47 | DDR2 | 0.85060773 |
| 48 | EPHB2 | 0.83779089 |
| 49 | TAOK3 | 0.83054854 |
| 50 | HIPK2 | 0.79282133 |
| 51 | MAP3K10 | 0.76181181 |
| 52 | EIF2AK3 | 0.74832856 |
| 53 | LCK | 0.73196051 |
| 54 | FGR | 0.70471251 |
| 55 | ACVR1B | 0.70207070 |
| 56 | YES1 | 0.68921203 |
| 57 | MAPK7 | 0.67827012 |
| 58 | PKN2 | 0.67234288 |
| 59 | GRK5 | 0.66482380 |
| 60 | STK39 | 0.66162989 |
| 61 | BMPR2 | 0.66021627 |
| 62 | IKBKB | 0.65785530 |
| 63 | PDGFRB | 0.64751256 |
| 64 | STK24 | 0.63290466 |
| 65 | ITK | 0.63189247 |
| 66 | MAP3K3 | 0.62036194 |
| 67 | PTK6 | 0.61628442 |
| 68 | LRRK2 | 0.61402751 |
| 69 | FYN | 0.58671353 |
| 70 | LMTK2 | 0.58622191 |
| 71 | SIK1 | 0.57147835 |
| 72 | IRAK3 | 0.55866830 |
| 73 | OXSR1 | 0.53808185 |
| 74 | RET | 0.52870993 |
| 75 | TAF1 | 0.51455488 |
| 76 | FLT3 | 0.49728170 |
| 77 | NEK9 | 0.48174303 |
| 78 | TGFBR1 | 0.47364035 |
| 79 | PDPK1 | 0.44917727 |
| 80 | TAOK1 | 0.44804304 |
| 81 | MAPKAPK2 | 0.44398312 |
| 82 | MAP3K6 | 0.43692385 |
| 83 | IGF1R | 0.42458468 |
| 84 | SIK2 | 0.41367212 |
| 85 | TEC | 0.39692524 |
| 86 | PRKD2 | 0.39088453 |
| 87 | PRKCD | 0.39062252 |
| 88 | MAP3K11 | 0.38683615 |
| 89 | MAP3K2 | 0.38129368 |
| 90 | PIK3CG | 0.38083046 |
| 91 | DMPK | 0.37971634 |
| 92 | TIE1 | 0.36176294 |
| 93 | MAPK11 | 0.36173324 |
| 94 | PRKG2 | 0.34813717 |
| 95 | CDK6 | 0.33733642 |
| 96 | PDK1 | 0.31269505 |
| 97 | MAP2K3 | 0.28833958 |
| 98 | KDR | 0.28348793 |
| 99 | CLK1 | 0.27005436 |
| 100 | ADRBK2 | 0.26561600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.28916833 |
| 2 | Asthma_Homo sapiens_hsa05310 | 4.06067144 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.54276847 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.40907464 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.31491914 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.25876019 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.69466403 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.68900711 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.54836031 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.51252640 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.45544856 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 2.14192608 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.80901123 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.74367129 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.74181535 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68287891 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63364211 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.62749917 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.57406385 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.52660146 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.48029811 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.47631634 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43893277 |
| 24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.42662376 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.42521667 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31441217 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29813053 |
| 28 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.29041974 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26727538 |
| 30 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.21539478 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.19278938 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17192161 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15360252 |
| 34 | Measles_Homo sapiens_hsa05162 | 1.12446586 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.11740023 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06109696 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02424083 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01794437 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99507330 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97914735 |
| 41 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91818457 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88973656 |
| 43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.84584558 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82662646 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72497179 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71888884 |
| 47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.70826112 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 0.68631275 |
| 49 | Mineral absorption_Homo sapiens_hsa04978 | 0.67398626 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66610830 |
| 51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65488277 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64604735 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64006869 |
| 54 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62050074 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60901222 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60833512 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.59147076 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59077151 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57534733 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.56373976 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.54931146 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53278177 |
| 63 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.53215374 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.52341143 |
| 65 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49627049 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49466485 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49027371 |
| 68 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46958046 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.46415528 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46266924 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45455733 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45388281 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44912432 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44238410 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41845540 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40325051 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.39246763 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.39211704 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39074122 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37339418 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.36872144 |
| 82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36004145 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.35197400 |
| 84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33863381 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30760699 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30250078 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.29767422 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.29698727 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29517521 |
| 90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.29231957 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28970399 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28778305 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.25709032 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25592394 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.24430019 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22992943 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22976366 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.22762298 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.22180949 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22068239 |

